Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis

Carol B. Hanna, Shan Yao, Mat Martin, Ernst Schönbrunn, Gunda I. Georg, Jeffrey T. Jensen, Rebecca A.D. Cuellar

Research output: Contribution to journalArticle

Abstract

We used a progressive elimination strategy to identify oocyte-specific WEE2 kinase inhibitors for potential non-hormonal contraceptives that target meiosis. Beginning with an in-house library of over 300,000 compounds, virtual high throughput screening identified 57 WEE2 inhibitors with preferential predicted binding over the somatic variant WEE1. Seven compounds were further evaluated in vitro by enzyme-linked immunosorbent assay to measure biochemical inhibition on WEE1 and WEE2 phosphorylation of CDK1. To assess specificity, we evaluated WEE2-mediated inhibition of meiosis using in vitro oocyte fertilization, and WEE1-mediated inhibition of mitosis using a somatic cell proliferation assay. Our results from these assays identified three candidates for further development: 6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy) phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (2), 6-(2,6-dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one (12), and 3-((6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)benzoic acid (16).

Original languageEnglish (US)
Pages (from-to)13363-13369
Number of pages7
JournalChemistrySelect
Volume4
Issue number45
DOIs
StatePublished - Dec 6 2019

Fingerprint

Contraceptive Agents
Assays
Screening
Immunosorbents
Phosphorylation
Benzoic Acid
Cell proliferation
Phosphotransferases
Throughput
Enzymes

Keywords

  • Cell cycle
  • Inhibitor
  • Meiosis
  • Oocyte
  • WEE kinase

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis. / Hanna, Carol B.; Yao, Shan; Martin, Mat; Schönbrunn, Ernst; Georg, Gunda I.; Jensen, Jeffrey T.; Cuellar, Rebecca A.D.

In: ChemistrySelect, Vol. 4, No. 45, 06.12.2019, p. 13363-13369.

Research output: Contribution to journalArticle

Hanna, Carol B. ; Yao, Shan ; Martin, Mat ; Schönbrunn, Ernst ; Georg, Gunda I. ; Jensen, Jeffrey T. ; Cuellar, Rebecca A.D. / Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis. In: ChemistrySelect. 2019 ; Vol. 4, No. 45. pp. 13363-13369.
@article{e12aa5431bcb4c18950928626f8ba899,
title = "Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis",
abstract = "We used a progressive elimination strategy to identify oocyte-specific WEE2 kinase inhibitors for potential non-hormonal contraceptives that target meiosis. Beginning with an in-house library of over 300,000 compounds, virtual high throughput screening identified 57 WEE2 inhibitors with preferential predicted binding over the somatic variant WEE1. Seven compounds were further evaluated in vitro by enzyme-linked immunosorbent assay to measure biochemical inhibition on WEE1 and WEE2 phosphorylation of CDK1. To assess specificity, we evaluated WEE2-mediated inhibition of meiosis using in vitro oocyte fertilization, and WEE1-mediated inhibition of mitosis using a somatic cell proliferation assay. Our results from these assays identified three candidates for further development: 6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy) phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (2), 6-(2,6-dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one (12), and 3-((6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)benzoic acid (16).",
keywords = "Cell cycle, Inhibitor, Meiosis, Oocyte, WEE kinase",
author = "Hanna, {Carol B.} and Shan Yao and Mat Martin and Ernst Sch{\"o}nbrunn and Georg, {Gunda I.} and Jensen, {Jeffrey T.} and Cuellar, {Rebecca A.D.}",
year = "2019",
month = "12",
day = "6",
doi = "10.1002/slct.201903696",
language = "English (US)",
volume = "4",
pages = "13363--13369",
journal = "ChemistrySelect",
issn = "2365-6549",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "45",

}

TY - JOUR

T1 - Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis

AU - Hanna, Carol B.

AU - Yao, Shan

AU - Martin, Mat

AU - Schönbrunn, Ernst

AU - Georg, Gunda I.

AU - Jensen, Jeffrey T.

AU - Cuellar, Rebecca A.D.

PY - 2019/12/6

Y1 - 2019/12/6

N2 - We used a progressive elimination strategy to identify oocyte-specific WEE2 kinase inhibitors for potential non-hormonal contraceptives that target meiosis. Beginning with an in-house library of over 300,000 compounds, virtual high throughput screening identified 57 WEE2 inhibitors with preferential predicted binding over the somatic variant WEE1. Seven compounds were further evaluated in vitro by enzyme-linked immunosorbent assay to measure biochemical inhibition on WEE1 and WEE2 phosphorylation of CDK1. To assess specificity, we evaluated WEE2-mediated inhibition of meiosis using in vitro oocyte fertilization, and WEE1-mediated inhibition of mitosis using a somatic cell proliferation assay. Our results from these assays identified three candidates for further development: 6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy) phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (2), 6-(2,6-dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one (12), and 3-((6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)benzoic acid (16).

AB - We used a progressive elimination strategy to identify oocyte-specific WEE2 kinase inhibitors for potential non-hormonal contraceptives that target meiosis. Beginning with an in-house library of over 300,000 compounds, virtual high throughput screening identified 57 WEE2 inhibitors with preferential predicted binding over the somatic variant WEE1. Seven compounds were further evaluated in vitro by enzyme-linked immunosorbent assay to measure biochemical inhibition on WEE1 and WEE2 phosphorylation of CDK1. To assess specificity, we evaluated WEE2-mediated inhibition of meiosis using in vitro oocyte fertilization, and WEE1-mediated inhibition of mitosis using a somatic cell proliferation assay. Our results from these assays identified three candidates for further development: 6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy) phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (2), 6-(2,6-dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one (12), and 3-((6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)benzoic acid (16).

KW - Cell cycle

KW - Inhibitor

KW - Meiosis

KW - Oocyte

KW - WEE kinase

UR - http://www.scopus.com/inward/record.url?scp=85076202842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076202842&partnerID=8YFLogxK

U2 - 10.1002/slct.201903696

DO - 10.1002/slct.201903696

M3 - Article

AN - SCOPUS:85076202842

VL - 4

SP - 13363

EP - 13369

JO - ChemistrySelect

JF - ChemistrySelect

SN - 2365-6549

IS - 45

ER -